Gland Pharma Limited (GLAND) — Voting Results

📢 Key Event
Shareholders approved reappointment of Udo Jahannes Vetter and appointment of William Robert Keller as Independent Directors via postal ballot resolutions.

🔄 What Changed
Reappointment of Vetter for second term and appointment of Keller as new director; approval of 0.15% profit commission for both directors capped at INR 5.5 million annually.

🔮 What's Next
Voting results to be announced by July 20, 2026, with final outcomes published on company website and stock exchanges.

💡 Investor Takeaway
Shareholders approved key leadership appointments and remuneration terms, ensuring continuity in governance with experienced directors.

Gland Pharma Limited's shareholders approved the reappointment of Udo Jahannes Vetter as Independent Director for a second term and William Robert Keller as a new Independent Director via postal ballot resolutions. The meeting, conducted through remote e-voting from June 19 to July 18, 2026, required electronic participation by July 18 deadline. Results were to be announced by July 20, 2026, with final outcomes published on company platforms. The resolutions, requiring special and ordinary approvals under SEBI and Companies Act norms, covered director appointments and profit-linked remuneration capped at INR 5.5 million annually.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLAND ✨ Ask AI About This